United Therapeutics Corp
UTHR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001082554
In the last 90 days, United Therapeutics Corp insiders filed 0 open-market purchases and 70 sales; 886 institutions reported holding it in 13F filings for Q2 2026, worth $22.6B in total; no superinvestor holds it.
Holders of 5% or more of UTHR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of United Therapeutics Corp, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of United Therapeutics Corp on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on United Therapeutics Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 20261:53 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| May 12, 202510:44 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 4.50%2.03M shares | −1.00 ppfrom 5.50%Below 5% | Mar 31, 2025 | SEC |
| Feb 10, 202510:25 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 5.50%2.46M shares | – | Dec 31, 2024 | SEC |
| Feb 5, 20257:10 AM ET | State Street Corp | 13G | 4.90%2.20M shares | NewBelow 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell United Therapeutics Corp shares.
No Form 144 notices for United Therapeutics Corp are on file.